MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

Strategies to enhance the induction of high magnitude T cell responses through vaccination are urgently needed. Major histocompatibility complex (MHC) class II–associated invariant chain (Ii) plays a critical role in antigen presentation, forming MHC class II peptide complexes for the generation of...

Полное описание

Библиографические подробности
Главные авторы:	Esposito, I, Cicconi, P, D'Alise, AM, Brown, A, Esposito, M, Swadling, L, Holst, PJ, Bassi, MR, Stornaiuolo, M, Mori, F, Vassilev, V, Li, W, Donnison, T, Gentile, C, Turner, B, von Delft, A, Del Sorbo, M, Barra, F, Contino, AM, Abbate, A, Novellino, E, Thomsen, AR, Christensen, JP, Lahm, A, Grazioli, F, Ammendola, V, Siani, L, Colloca, S, Klenerman, P, Nicosia, A, Dorrell, L, Folgori, A, Capone, S, Barnes, E
Другие авторы:	PEACHI Consortium
Формат:	Journal article
Язык:	English
Опубликовано:	American Association for the Advancement of Science 2020

Схожие документы

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
по: Kelly, C, и др.
Опубликовано: (2016)

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
по: Kelly, C, и др.
Опубликовано: (2016)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
по: Swadling, L, и др.
Опубликовано: (2014)

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
по: Angiolo Pierantoni, и др.
Опубликовано: (2015-01-01)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
по: Capone, S, и др.
Опубликовано: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
по: Capone, S, и др.
Опубликовано: (2010)

A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection
по: Hartnell, F, и др.
Опубликовано: (2019)

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
по: Swadling, L, и др.
Опубликовано: (2016)

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
по: Swadling, L, и др.
Опубликовано: (2016)

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
по: Barnes, E, и др.
Опубликовано: (2012)

A highly immunogenic novel genetic vaccine against HCV
по: Del Sorbo, M, и др.
Опубликовано: (2012)

Hepatitis Hide and Seek
по: Barnes, E, и др.
Опубликовано: (2012)

Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors
по: Fulvia Troise, и др.
Опубликовано: (2024-03-01)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
по: Colloca, S, и др.
Опубликовано: (2012)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
по: Federico Napolitano, и др.
Опубликовано: (2021-04-01)

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
по: Felicity Hartnell, и др.
Опубликовано: (2019-01-01)

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes
по: Donnison, T, и др.
Опубликовано: (2020)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
по: Folgori, A, и др.
Опубликовано: (2009)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
по: Kelly, C, и др.
Опубликовано: (2011)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
по: Leo Swadling, и др.
Опубликовано: (2016-08-01)

Historical analysis of rainfall-triggered rockfalls: the case study of the disaster of the ancient hydrothermal Sclafani Spa (Madonie Mts, northern-central Sicily, Italy) in 1851
по: A. Contino, и др.
Опубликовано: (2017-12-01)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
по: Reyes-Sandoval, A, и др.
Опубликовано: (2010)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
по: Reyes-Sandoval, A, и др.
Опубликовано: (2011)

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses, (vol 78, pg 152, 2010)
по: Reyes-Sandoval, A, и др.
Опубликовано: (2011)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
по: Green, C, и др.
Опубликовано: (2015)

Formyl-Peptide Receptor 2 Signaling Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming of Lung Cancer Cells
по: Tiziana Pecchillo Cimmino, и др.
Опубликовано: (2022-08-01)

Formyl-peptide receptor 2 signalling triggers aerobic metabolism of glucose through Nox2-dependent modulation of pyruvate dehydrogenase activity
по: Tiziana Pecchillo Cimmino, и др.
Опубликовано: (2023-10-01)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
по: Barnes, E, и др.
Опубликовано: (2011)

Pathophysiology of ischaemic heart disease
по: Pocock, MO, и др.
Опубликовано: (2017)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
по: Alessandra Vitelli, и др.
Опубликовано: (2017-12-01)

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
по: Anna Morena D’Alise, и др.
Опубликовано: (2019-06-01)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
по: Barnes, E, и др.
Опубликовано: (2009)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
по: Spencer, A, и др.
Опубликовано: (2014)

Formyl Peptide Receptor 2-Dependent cPLA2 and 5-LOX Activation Requires a Functional NADPH Oxidase
по: Tiziana Pecchillo Cimmino, и др.
Опубликовано: (2024-02-01)

Targeting HIV-1 Where It Hurts
по: Ahmed, T, и др.
Опубликовано: (2013)

The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
по: Ondondo, B, и др.
Опубликовано: (2013)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
по: Kelly, C, и др.
Опубликовано: (2012)

Entanglement entropy in conformal quantum mechanics
по: Michele Arzano, и др.
Опубликовано: (2023-10-01)

Innovating through Clusters
по: Chiara D'Alise, и др.
Опубликовано: (2014-11-01)

SoCIAL – training cognition in schizophrenia: a pilot study
по: Palumbo D, и др.
Опубликовано: (2017-07-01)